Beilstein J. Org. Chem. 2018, 14, 2411–2417.
12.Blackman, A. J.; Hambley, T. W.; Picker, K.; Taylor, W. C.;
phenylethynyl) trifluoroacetanilides 5 and arylboronic acids, by
avoiding the isolation of intermediate indoles 9. Starting from
indoles 14, or from o-(o-aminophenylethynyl)aniline 15a, selec-
tive formation of 12-unsubstituted[1,2-c]quinazolines 13 was
accomplished, without competitive formation of products
derived from C-3 functionalization at the indole moiety.
Thirasasana, N. Tetrahedron Lett. 1987, 28, 5561–5562.
13.Douki, K.; Ono, H.; Taniguchi, T.; Shimokawa, J.; Kitamura, M.;
Fukuyama, T. J. Am. Chem. Soc. 2016, 138, 14578–14581.
14.Frère, S.; Thiéry, V.; Bailly, C.; Besson, T. Tetrahedron 2003, 59,
15.Billimoria, A. D.; Cava, M. P. J. Org. Chem. 1994, 59, 6777–6782.
Supporting Information
16.Dai, X.; Liu, H.; Palani, A.; He, S.; Lai, Z.; Nargund, R.;
Marcantonio, K.; Xiao, D.; Brockunier, L. L.; Zorn, N.; Dang, Q.;
Peng, X.; Li, P. Tetracyclic heterocycle compounds and methods of
use thereof for the treatment of hepatitis c. WO Patent
WO2014/123794A1, Aug 14, 2014.
Supporting Information File 1
Experimental procedures, characterization data and copies
of NMR spectra.
17.Guo, S.; Tao, L.; Zhang, W.; Zhang, X.; Fan, X. J. Org. Chem. 2015,
18.Liu, Q.; Yang, H.; Jiang, Y.; Zhao, Y.; Fu, H. RSC Adv. 2013, 3,
19.Arcadi, A.; Cacchi, S.; Cassetta, A.; Fabrizi, G.; Parisi, L. M. Synlett
Acknowledgements
We gratefully acknowledge the University of L’Aquila and the
20.Cacchi, S.; Marinelli, F. In Organopalladium chemistry for Organic
Synthesis; Neghishi, E.; de Meijere, A., Eds.; John Wiley & Sons: New
York, 2002; Vol. 2, pp 2227–2244.
Sapienza, University of Rome, for financial support.
ORCID® iDs
21.Battistuzzi, G.; Cacchi, S.; Fabrizi, G. Eur. J. Org. Chem. 2002,
2671–2681.
See for a review.
22.Xu, M.; Xu, K.; Wang, S.; Yao, Z.-J. Tetrahedron Lett. 2013, 54,
References
1. Demeunynck, M.; Baussanne, I. Curr. Med. Chem. 2013, 20, 794–814.
23.Arcadi, A.; Cacchi, S.; Fabrizi, G.; Ghirga, F.; Goggiamani, A.;
Iazzetti, A.; Marinelli, F. Synthesis 2018, 1133–1140.
2. Tucker, A. M.; Grundt, P. ARKIVOC 2012, No. i, 546–569.
3. Adams, M.; Mahringer, A.; Kunert, O.; Fricker, G.; Efferth, T.; Bauer, R.
4. Hochfellner, C.; Evangelopoulos, D.; Zloh, M.; Wube, A.;
Guzman, J. D.; McHugh, T. D.; Kunert, O.; Bhakta, S.; Bucar, F.
5. Vaidya, S. D.; Argade, N. P. Org. Lett. 2013, 15, 4006–4009.
24.Arcadi, A.; Cacchi, S.; Fabrizi, G.; Goggiamani, A.; Iazzetti, A.;
Marinelli, F. Org. Biomol. Chem. 2013, 11, 545–548.
25.Cacchi, S.; Fabrizi, G.; Pace, P.; Marinelli, F. Synlett 1999, 620–622.
27.Nathubhai, A.; Patterson, R.; Woodman, T. J.; Sharp, H. E. C.;
Chui, M. T. Y.; Chung, H. H. K.; Lau, S. W. S.; Zheng, J.; Lloyd, M. D.;
Thompson, A. S.; Threadgill, M. D. Org. Biomol. Chem. 2011, 9,
6. Wang, C.; Zhang, L.; Ren, A.; Lu, P.; Wang, Y. Org. Lett. 2013, 15,
7. Nelson, A. C.; Kalinowski, E. S.; Jacobson, T. L.; Grundt, P.
Tetrahedron Lett. 2013, 54, 6804–6806.
28.The use of a lower excess of DMFDMA decreased the yields of
products.
8. Sharma, V. M.; Prasanna, P.; Seshu, K. V. A.; Renuka, B.;
Rao, C. V. L.; Kumar, G. S.; Narasimhulu, C. P.; Babu, P. A.;
Puranik, R. C.; Subramanyam, D.; Venkateswarlu, A.; Rajagopal, S.;
Kumar, K. B. S.; Rao, C. S.; Mamidi, N. V. S. R.; Deevi, D. S.;
Ajaykumar, R.; Rajagopalan, R. Bioorg. Med. Chem. Lett. 2002, 12,
29.Utimoto, K.; Miwa, H.; Nozaki, H. Tetrahedron Lett. 1981, 22,
30.Iritani, K.; Matsubara, S.; Utimoto, K. Tetrahedron Lett. 1988, 29,
31.Arcadi, A.; Cacchi, S.; Fabrizi, G.; Marinelli, F.; Parisi, L. M.
32.Abbiati, G.; Arcadi, A.; Chiarini, M.; Marinelli, F.; Pietropaolo, E.;
Rossi, E. Org. Biomol. Chem. 2012, 10, 7801–7808.
9. Rohini, R.; Reddy, P. M.; Shanker, K.; Hu, A.; Ravinder, V.
Eur. J. Med. Chem. 2010, 45, 1200–1205.
10.Rohini, R.; Reddy, P. M.; Shanker, K.; Hu, A.; Ravinder, V.
J. Braz. Chem. Soc. 2010, 21, 897–904.
11.Rohini, R.; Shanker, K.; Reddy, P. M.; Sekhar, V. C.; Ravinder, V.
2416